Yanhai Yin1, Fen Li1, Liangqian Tong2, Chunru Chen1, Bo Yuan3. 1. Department of Nuclear medicine, Hainan Affiliated Hospital of Hainan Medical University, Hainan general Hospital, Haikou, Hainan Province, China. 2. Department of Nuclear medicine, Haikou general Hospital, Haikou, Hainan Province, China. 3. Department of General surgery, Hainan Affiliated Hospital of Hainan Medical University, Hainan general Hospital, #19 Xiuhua Road, Xiuying District, Haikou, Hainan Province, 570311, China. yuanbob@aliyun.com.
Abstract
BACKGROUND: The study aimed to evaluate the relationship of IL-1B/IL-1RN polymorphisms to the predisposition of head and neck cancer (HNC) in a Chinese Han population. METHODS: Nine single-nucleotide polymorphisms (SNPs) in IL-1B/IL-1RN were genotyped based on Agena MassARRAY platform. Logistic regression models were used to analyze the genetic association between these SNPs and HNC risk by calculating odds ratios (ORs) and 95% confidence intervals (CI). Haplotype analysis were performed using Haploview program and logistic regression model. RESULTS: The genetic association between rs1143643 in IL-1B and the higher risk of HNC was found (OR = 1.23, 95% CI 1.04-1.46) in the overall. IL-1RN rs17042888 was related to a reduced risk of HNC in the subjects aged > 46 years (OR = 0.70, 95% CI: 0.50-0.98) and in females (OR = 0.71, 95% CI 0.52-0.98), while rs1143643 increased the predisposition of HNC among females (OR = 1.76, 95% CI 1.13-2.74). Furthermore, rs1143643 had an increased susceptibility to thyroid carcinoma (OR = 1.61, 95% CI 1.10-2.34). Moreover, compared with stage I-II, the frequency of IL-1RN rs452204-AG genotype was lower in patients with stage III-IV. CONCLUSIONS: IL-1B (rs1143643) and IL-1RN (rs17042888 and rs452204) polymorphisms might be related to the individual susceptibility of HNC in the Chinese Han population. These results might help to improve the understanding of IL-1B and IL-1RN genes in the occurrence of HNC.
BACKGROUND: The study aimed to evaluate the relationship of IL-1B/IL-1RN polymorphisms to the predisposition of head and neck cancer (HNC) in a Chinese Han population. METHODS: Nine single-nucleotide polymorphisms (SNPs) in IL-1B/IL-1RN were genotyped based on Agena MassARRAY platform. Logistic regression models were used to analyze the genetic association between these SNPs and HNC risk by calculating odds ratios (ORs) and 95% confidence intervals (CI). Haplotype analysis were performed using Haploview program and logistic regression model. RESULTS: The genetic association between rs1143643 in IL-1B and the higher risk of HNC was found (OR = 1.23, 95% CI 1.04-1.46) in the overall. IL-1RNrs17042888 was related to a reduced risk of HNC in the subjects aged > 46 years (OR = 0.70, 95% CI: 0.50-0.98) and in females (OR = 0.71, 95% CI 0.52-0.98), while rs1143643 increased the predisposition of HNC among females (OR = 1.76, 95% CI 1.13-2.74). Furthermore, rs1143643 had an increased susceptibility to thyroid carcinoma (OR = 1.61, 95% CI 1.10-2.34). Moreover, compared with stage I-II, the frequency of IL-1RNrs452204-AG genotype was lower in patients with stage III-IV. CONCLUSIONS:IL-1B (rs1143643) and IL-1RN (rs17042888 and rs452204) polymorphisms might be related to the individual susceptibility of HNC in the Chinese Han population. These results might help to improve the understanding of IL-1B and IL-1RN genes in the occurrence of HNC.
Entities:
Keywords:
Genetic polymorphism; Head and neck cancer; IL-1B and IL-1RN; Susceptibility
Authors: Moshe Elkabets; Vera S G Ribeiro; Charles A Dinarello; Suzanne Ostrand-Rosenberg; James P Di Santo; Ron N Apte; Christian A J Vosshenrich Journal: Eur J Immunol Date: 2010-12 Impact factor: 5.532
Authors: Jiachen Zhou; Dominique S Michaud; Scott M Langevin; Michael D McClean; Melissa Eliot; Karl T Kelsey Journal: Int J Cancer Date: 2012-10-11 Impact factor: 7.396
Authors: Madelyn Espinosa-Cotton; Samuel N Rodman Iii; Kathleen A Ross; Isaac J Jensen; Kenley Sangodeyi-Miller; Ayana J McLaren; Rachel A Dahl; Katherine N Gibson-Corley; Adam T Koch; Yang-Xin Fu; Vladimir P Badovinac; Douglas Laux; Balaji Narasimhan; Andrean L Simons Journal: J Immunother Cancer Date: 2019-03-19 Impact factor: 13.751